The University of Manchester, School of Cancer and Enabling Sciences, Faculty of Medical and Human Sciences, Oxford Road, Manchester M13 9PL, UK.
Nephrol Dial Transplant. 2012 Jul;27(7):2776-80. doi: 10.1093/ndt/gfr757. Epub 2012 Mar 22.
Chronic kidney disease (CKD) is increasingly prevalent worldwide. Furthermore, obesity is now a global problem with major health implications. There is a clear association between obesity and the development of CKD but it is not known whether obesity is a risk factor for the progression of pre-existing kidney disease. We examined the relationship between the body mass index (BMI) and the rate of progression of CKD in non-diabetic adults.
The Chronic Renal Insufficiency Standards Implementation Study (CRISIS) is a prospective observational study in a predominantly white population in Greater Manchester. From the CRISIS database, we assessed rate of progression of CKD in 499 adults attending the hospital. Baseline measurements including BMI were obtained and estimated glomerular filtration rate (eGFR) was monitored. The rate of deterioration of eGFR was derived over time, defined as ΔeGFR (mL/min/1.73 m2/year) and assessed using univariate analysis of variance.
In the groups as a whole, no relationship between BMI and ΔeGFR was shown. Dividing the subjects into obese (BMI≥30) and non-obese (BMI<30) groups and further breakdown into CKD stages 3, 4 and 5, also showed no relationship between BMI and ΔeGFR. Univariate analysis of variance was used.
Neither BMI as a continuous variable nor obesity (BMI≥30) as a categorical variable was associated with an increased rate of progression of existing CKD in this predominantly white population.
慢性肾脏病(CKD)在全球范围内日益流行。此外,肥胖现在是一个全球性问题,对健康有重大影响。肥胖与 CKD 的发展之间存在明确的关联,但尚不清楚肥胖是否是导致先前存在的肾脏疾病进展的危险因素。我们研究了非糖尿病成年人的体重指数(BMI)与 CKD 进展速度之间的关系。
慢性肾功能不全标准实施研究(CRISIS)是一项在大曼彻斯特地区以白种人为主的前瞻性观察性研究。我们从 CRISIS 数据库中评估了 499 名在医院就诊的成年人的 CKD 进展速度。获得了包括 BMI 在内的基线测量值,并监测了估计肾小球滤过率(eGFR)。通过时间推导得出 eGFR 恶化的速度,定义为 ΔeGFR(mL/min/1.73 m2/年),并使用单变量方差分析进行评估。
在整个组中,BMI 与 ΔeGFR 之间没有关系。将受试者分为肥胖组(BMI≥30)和非肥胖组(BMI<30),并进一步分为 CKD 3 期、4 期和 5 期,BMI 与 ΔeGFR 之间也没有关系。使用单变量方差分析。
在这个以白种人为主的人群中,BMI 作为连续变量或肥胖(BMI≥30)作为分类变量均与现有的 CKD 进展速度增加无关。